Surgical treatment for hydrosalpinx increases the expression of integrin αvβ3 in the endometrium during the implantation window

Experimental and Therapeutic Medicine

Volumn 4, Issue 3, 2012, Pages 415-418

  Zhong, Yiping ^a   Li, Jin ^b   Wu, Haiao ^a   Ying, Ying ^a   Liu, Yafeng ^a   Zhou, Canquan ^a   Xu, Yanwen ^a   Shen, Xiaoting ^a   Qi, Quan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

Author keywords

Endometrium; Hydrosalpinx; Implantation window; Integrin v 3

Indexed keywords

VITRONECTIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FERTILIZATION IN VITRO; HUMAN; HYDROSALPINX; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NIDATION; PROTEIN EXPRESSION; TREATMENT OUTCOME; UTERINE TUBE; UTERINE TUBE OCCLUSION;

EID: 84863908343     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.610     Document Type: Article

References (12)

1. Lessey BA: Endometrial integrins and the establishment of uterine receptivity. Hum Reprod 13: S247-S258, 1998.
2. Taylor E and Gomel V: The uterus and fertility. Fertil Steril 89: 1-16, 2008.
3. Mijatovic V, Veersema S, Emanuel MH, Schats R and Hompes PG: Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril 93: 1338-1342, 2010.
4. Seli E, Kayisli UA, Cakmak H, Bukulmez O, Bildirici I, Guzeloglu-Kayisli O and Arici A: Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod 20: 3012-3017, 2005.
5. Dou Q, Willians RS and Chegini N: Expression of integrin messenger ribonucleic acid in human endometrium: a quantitative reverse transcription polymerase chain reaction study. Fertil Steril 71: 347-353, 1999.
6. Lessey BA: Adhesion molecules and implantation. J Reprod Immunol 55: 101-112, 2002.
7. Apparao KB, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR and Lessey BA: Osteopontin and its receptor alphav-beta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 86: 4991-5000, 2001.
8. Lessey BA and Castelbaum AJ: Integrins and implantation in the human. Rev Endocr Metab Disord 3: 107-117, 2002.
9. Petersen A, Bentin-Ley U, Ravn V, Qvortrup K, Sørensen S, Islin H, Sjögren A, Mosselmann S and Hamberger L: The anti-progesterone Org31710 inhibits human blastocyst-endometrial interactions in vitro. Fertil Steril 83: 1255-1263, 2002.
10. Lessey BA: Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids 68: 809-815, 2003.
11. Bulletti C, Flamigni C and de Ziegler D: Implantation markers and endometriosis. Reprod Biomed Online 11: 464-468, 2005.
12. Bildirici I, Bukulmez O, Ensari A, Yarali H and Gurgan T: A prospective evaluation of the effect of salpingectomy on endo-metrial receptivity in cases of women with communicating hydrosalpinges. Hum Reprod 16: 2422-2426, 2001.